Efficacy of Combined Fractional Er:Glass and Thulium Lasers Versus Microneedling for Atrophic Acne Scars
84 patients around the world
Available in Brazil
Acne scars are common and can have a lasting impact on self-esteem, social relationships,
and quality of life. Several treatment options exist, but many patients continue to seek
better results. Microneedling is a minimally invasive technique that uses small needles
to stimulate skin repair. Fractional lasers, such as Erbium:Glass (1540-1550 nm) and
Thulium (1927 nm), deliver energy into the skin to promote remodeling of deeper and more
superficial layers. The combination of these two fractional lasers may provide a more
comprehensive treatment approach for acne scars.
This clinical trial will directly compare these two options: microneedling versus the
combined use of fractional Erbium:Glass and Thulium lasers. A total of 84 adults between
18 and 30 years old with atrophic acne scars will take part. Participants will be
randomly chosen by a draw (like a lottery) to receive one of the two groups. Both groups
will receive three treatment sessions, with four weeks between each session.
The main goal is to determine which treatment leads to greater improvement in acne scars.
Improvement will be measured by independent evaluators who will compare standardized
before-and-after photographs using a grading scale. Participants will also report their
own satisfaction with the results and how well they tolerated the treatments. Follow-up
assessments will occur up to 90 days after the last session.
University of Nove de Julho
1Research sites
84Patients around the world
This study is for people with
Acne
Atrophic Acne Scars
Requirements for the patient
To 45 Years
All Gender
Medical requirements
Fitzpatrick skin phototypes I to VI.
Presence of atrophic acne scars on the face.
Decompensated systemic diseases.
Any active infection (e.g., viral such as herpes, bacterial, or fungal).
Pregnant or breastfeeding women.
Presence of hypertrophic or keloid scars.
Current use of anticoagulant or antiplatelet medications.
History of hemophilia or coagulation disorders.
Current use of anti-inflammatory drugs or corticosteroids.
Use of retinoids, including isotretinoin, within the past 6 months.
Exposure to sunlight within the past 15 days.
Undergoing any aesthetic facial treatment or having undergone scar treatments in the facial region within 180 days prior to study initiation.
Presence of active acne (occasional isolated lesions will not be considered exclusion criteria).
Sites
Espaço Conceito Medical San
Recruiting
Av. Queiroz Filho, 1700 - 205 a - Vila Hamburguesa, São Paulo - SP, 05319-000, Brazil